ATE49884T1 - Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis. - Google Patents

Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.

Info

Publication number
ATE49884T1
ATE49884T1 AT85400564T AT85400564T ATE49884T1 AT E49884 T1 ATE49884 T1 AT E49884T1 AT 85400564 T AT85400564 T AT 85400564T AT 85400564 T AT85400564 T AT 85400564T AT E49884 T1 ATE49884 T1 AT E49884T1
Authority
AT
Austria
Prior art keywords
amoebiasis
manufacture
medicinal product
saccharomyces yeast
yeasts
Prior art date
Application number
AT85400564T
Other languages
English (en)
Inventor
Philippe Gayral
Bernard Hublot
Original Assignee
Biocodex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex Lab filed Critical Biocodex Lab
Application granted granted Critical
Publication of ATE49884T1 publication Critical patent/ATE49884T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85400564T 1985-03-22 1985-03-22 Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis. ATE49884T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85400564A EP0195870B1 (de) 1985-03-22 1985-03-22 Verwendung von Saccharomyces-Hefen für die Herstellung eines Arzneimittels gegen Amöbiasis

Publications (1)

Publication Number Publication Date
ATE49884T1 true ATE49884T1 (de) 1990-02-15

Family

ID=8194509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85400564T ATE49884T1 (de) 1985-03-22 1985-03-22 Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.

Country Status (4)

Country Link
US (1) US4643897A (de)
EP (1) EP0195870B1 (de)
AT (1) ATE49884T1 (de)
DE (1) DE3575671D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
FR2711528B1 (fr) * 1993-10-25 1996-02-09 Biocodex Lab Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose.
DE4336888A1 (de) * 1993-10-28 1995-05-04 Thiemann Arzneimittel Gmbh Produkt, erhältlich aus Hefezellen von Saccharomyces boulardii und dessen Verwendung
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
US20060292171A1 (en) * 2003-10-13 2006-12-28 Nestec S.A. Moderating the effect of endotoxins
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
ATE460081T1 (de) * 2004-07-21 2010-03-15 Alltech Inc Zusammensetzung und ihre verwendung zur bekämpfung von protozoen-infektionen von tieren
EP1693445B2 (de) * 2005-02-18 2016-06-08 Gnosis S.p.A. Verfahren zur Herstellung von Hefe-Mikrokapseln
WO2007149437A1 (en) * 2006-06-16 2007-12-27 Alltech, Inc. Reduction of antibiotic resistance in bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB930107A (en) * 1960-01-11 1963-07-03 Giuseppe Carlo Sigurta Therapeutic oral preparation of micro-organisms
FR1538957A (fr) * 1964-02-17 1968-09-13 Robert & Carriere Lab Perfectionnement à la culture des levures
BE652331A (de) * 1964-08-26 1965-02-26
FR2096887A1 (en) * 1970-07-10 1972-03-03 Griffon Henri Compsn contg dried yeast with high living cell count - - for dietetic use and treating intestinal disorders
FR2228470A1 (en) * 1973-05-09 1974-12-06 Degemont Marguerite Therapeutic compsn. contg. vitamin A, sulphur and live yeast - for treatment of disorders of the ear, nose and throat
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis

Also Published As

Publication number Publication date
EP0195870B1 (de) 1990-01-31
US4643897A (en) 1987-02-17
EP0195870A1 (de) 1986-10-01
DE3575671D1 (de) 1990-03-08

Similar Documents

Publication Publication Date Title
ATE158182T1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
ATE183087T1 (de) Verwendung von beta-hydroxy-beta- methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen
EP1019072A4 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
DE3583849D1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
NO931267D0 (no) Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
CA2118121A1 (en) Methods and compositions for the treatment of diseases with interferon while reducing side effects
AU7589587A (en) Low dosage of interferon to enhance vaccine efficiency
GEP20002142B (en) Method for Treatment and Prevention of TNF Mediated Diseases
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
ATE49884T1 (de) Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
ATE79749T1 (de) Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
CA2111470A1 (en) Accelerated wound healing
FR2624010B1 (fr) Compositions topiques heterogenes a base de microgranules de cafeine et/ou de ses derives, utiles comme amincissant et/ou dans le traitement de la cellulite, ainsi que leur preparation
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
ATE41604T1 (de) Arzneimittel zur oralen verabreichung, bestehend einerseits aus 9-alpha,11-beta-dichlor-16-alphamethyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-diene-3,20-dione als wirksubstanz und andererseits aus einem inerten pharmazeutischen exipiens, das die wirksamkeit des produkts im rektum oder im kolon sich entfalten laesst, sowie die verwendung dieser wirksubstanz zur
RU94004903A (ru) Противоопухолевые и иммуномодулирующие средства и способы лечения онкологических больных, кожных заболеваний и трофических язв
RU93043630A (ru) Способ улучшения процессов памяти
SU940774A1 (ru) Способ лечени пародонтоза у лиц пожилого и старческого возраста
Török et al. Long Term Post‐Treatment Follow‐up of Onychomycoses Treated with Ketoconazole/Langzeit‐Nachuntersuchungen mit Ketokonazol behandelten Onychomykosen

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time